References
- Araújo AV, Arruda VM, Gustavo SD, Evêncio LB, Maria Do Carmo CA, Lafayette SS, Wanderley AG. 2006. Atividade cicatrizante e estudo toxicológico pré-clínico do fitoterápico Sanativo®. Acta Farmacéutica Bonaerense. 25(4):544–549.
- Bastos GN, Silveira AJ, Salgado CG, Picanço-Diniz DL, do Nascimento JL. 2008. Physalis angulata extract exerts anti-inflammatory effects in rats by inhibiting different pathways. J Ethnopharmacol. 118(2):246–251. doi:https://doi.org/10.1016/j.jep.2008.04.005
- Fehrenbacher JC, Vasko MR, Duarte DB. 2012. Models of inflammation: carrageenan- or complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat. Curr Protoc Pharmacol. 56(1):4–5.
- Guimarães ET, Lima MS, Santos LA, Ribeiro IM, Tomassini TB, Ribeiro dos Santos R, dos Santos WL, Soares MB. 2009. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis. J Antimicrob Chemother. 64(1):84–87. doi:https://doi.org/10.1093/jac/dkp170
- Lima MS, Evangelista AF, Santos GG, Ribeiro IM, Tomassini TC, Pereira Soares MB, Villarreal CF. 2014. Antinociceptive properties of physalins from Physalis angulata. J Nat Prod. 77(11):2397–2403. doi:https://doi.org/10.1021/np5003093
- Nogueira RC, Rocha VP, Nonato FR, Tomassini TC, Ribeiro IM, dos Santos RR, Soares B. 2013. Genotoxicity and antileishmanial activity evaluation of Physalis angulata concentrated ethanolic extract. Environ Toxicol Pharmacol. 36(3):1304–1311. doi:https://doi.org/10.1016/j.etap.2013.10.013
- Pinto LA, Meira CS, Villarreal CF, Vannier-Santos MA, de Souza CV, Ribeiro IM, Tomassini TC, Galvão-Castro B, Soares MB, Grassi MF. 2016. Physalin F, a seco-steroid from Physalis angulata L., has immunosuppressive activity in peripheral blood mononuclear cells from patients with HTLV1-associated myelopathy. Biomed Pharmacother. 79:129–134. doi:https://doi.org/10.1016/j.biopha.2016.01.041
- Sá MS, de Menezes MN, Krettli AU, Ribeiro IM, Tomassini TC, Ribeiro dos Santos R, de Azevedo W, Soares MB. 2011. Antimalarial activity of physalins B, D, F, and G. J Nat Prod. 74(10):2269–2272. doi:https://doi.org/10.1021/np200260f
- Soares MB, Bellintani MC, Ribeiro IM, Tomassini TC, Ribeiro dos Santos R. 2003. Inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis angulata L. Eur J Pharmacol. 459(1):107–112. doi:https://doi.org/10.1016/s0014-2999(02)02829-7
- Soares MB, Brustolim D, Santos LA, Bellintani MC, Paiva FP, Ribeiro YM, Tomassini TC, Ribeiro dos Santos R. 2006. Physalins B, F and G, seco-steroids purified from Physalis angulata L., inhibit lymphocyte function and allogeneic transplant rejection. Int Immunopharmacol. 6(3):408–414. doi:https://doi.org/10.1016/j.intimp.2005.09.007
- Vieira AT, Pinho V, Lepsch LB, Scavone C, Ribeiro IM, Tomassini T, Ribeiro-dos-Santos R, Soares MB, Teixeira MM, Souza DG. 2009. Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury. Br J Pharmacol. 146(2):244–251.
- Wagner H, Ulrich-Merzenich G. 2009. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomed. 16(2–3):97–110. doi:https://doi.org/10.1016/j.phymed.2008.12.018
- Wu SY, Leu YL, Chang YL, Wu TS, Kuo PC, Liao YR, Teng CM, Pan SL. 2012. Physalin F induces cell apoptosis in human renal carcinoma cells by targeting NF-KappaB and generating reactive oxygen species. PLoS One. 7(7):e40727. doi:https://doi.org/10.1371/journal.pone.0040727
- Yang Y, Zhang Z, Li S, Ye X, Li X, He K. 2014. Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis. Fitoterapia. 92:133–147. doi:https://doi.org/10.1016/j.fitote.2013.10.010